PGHH
Procter & Gamble Hygiene and Health Care Limited
Feminine hygiene and healthcare products under Whisper and Vicks brands
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products›Personal Care
us.pg.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-19
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
PGHH (Procter & Gamble Hygiene and Health Care) sells feminine hygiene and healthcare products to Indian consumers, led by the Whisper and Vicks brands, which the company describes as India's leading feminine hygiene brand and India's No. 1 healthcare brand.
Company snapshot
6thBy market cap
Ranked among 10 companies in Personal Care.
What we see
- ✓Net margin of 20.0% — the business keeps a healthy share of every rupee it earns.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,138 Cr | 1,133 Cr | 1,002 Cr | 932 Cr | 1,135 Cr | 1,248 Cr | 992 Cr | 937 Cr | 1,150 Cr | 1,262 Cr | 941 Cr | 891 Cr |
| Operating expenses (approx.) | 853 Cr | 824 Cr | 745 Cr | 813 Cr | 845 Cr | 877 Cr | 782 Cr | 671 Cr | 865 Cr | 860 Cr | 723 Cr | 721 Cr |
| EBITDA | 285 Cr | 310 Cr | 257 Cr | 118 Cr | 290 Cr | 371 Cr | 210 Cr | 266 Cr | 285 Cr | 402 Cr | 218 Cr | 170 Cr |
| OPM % | 25.0% | 27.3% | 25.7% | 12.7% | 25.6% | 29.7% | 21.1% | 28.4% | 24.8% | 31.8% | 23.2% | 19.1% |
| Other income | 16 Cr | 16 Cr | 14 Cr | 7 Cr | 9 Cr | 10 Cr | 19 Cr | 8 Cr | 10 Cr | 12 Cr | 12 Cr | 9 Cr |
| Interest | 2 Cr | 3 Cr | 22 Cr | -0.08 Cr | 2 Cr | 7 Cr | 6 Cr | 0.07 Cr | 4 Cr | 3 Cr | 3 Cr | 0.27 Cr |
| Depreciation | 14 Cr | 14 Cr | 15 Cr | 13 Cr | 12 Cr | 10 Cr | 10 Cr | 9 Cr | 9 Cr | 10 Cr | 10 Cr | 10 Cr |
| Profit before tax | 284 Cr | 309 Cr | 234 Cr | 112 Cr | 285 Cr | 364 Cr | 213 Cr | 265 Cr | 282 Cr | 402 Cr | 218 Cr | 170 Cr |
| Tax % | 25.9% | 25.8% | 34.0% | 27.8% | 25.7% | 26.2% | 26.6% | 27.4% | 25.5% | 25.0% | 29.8% | 25.6% |
| Net profit | 211 Cr | 229 Cr | 154 Cr | 81 Cr | 212 Cr | 269 Cr | 156 Cr | 192 Cr | 210 Cr | 301 Cr | 153 Cr | 126 Cr |
| EPS (₹) | ₹64.91 | ₹70.51 | ₹47.56 | ₹24.97 | ₹65.28 | ₹82.74 | ₹48.09 | ₹59.17 | ₹64.65 | ₹92.87 | ₹47.17 | ₹38.90 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,419 Cr | 2,455 Cr | 2,947 Cr | 3,002 Cr | 3,574 Cr | 3,901 Cr | 3,918 Cr | 4,206 Cr | 4,290 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 1,755 Cr | 1,840 Cr | 2,337 Cr | 2,398 Cr | 2,690 Cr | 3,071 Cr | 3,049 Cr | 3,235 Cr | 3,119 Cr | Sign in free for the trailing twelve months |
| EBITDA | 665 Cr | 615 Cr | 609 Cr | 604 Cr | 884 Cr | 830 Cr | 869 Cr | 970 Cr | 1,171 Cr | Sign in free for the trailing twelve months |
| OPM % | 27.5% | 25.1% | 20.7% | 20.1% | 24.7% | 21.3% | 22.2% | 23.1% | 27.3% | Sign in free for the trailing twelve months |
| Other income | 77 Cr | 24 Cr | 53 Cr | 44 Cr | 39 Cr | 24 Cr | 41 Cr | 52 Cr | 42 Cr | Sign in free for the trailing twelve months |
| Interest | 10 Cr | 5 Cr | 5 Cr | 6 Cr | 6 Cr | 11 Cr | 11 Cr | 27 Cr | 9 Cr | Sign in free for the trailing twelve months |
| Depreciation | 60 Cr | 52 Cr | 50 Cr | 48 Cr | 48 Cr | 53 Cr | 58 Cr | 57 Cr | 37 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 672 Cr | 582 Cr | 607 Cr | 594 Cr | 870 Cr | 790 Cr | 839 Cr | 939 Cr | 1,167 Cr | Sign in free for the trailing twelve months |
| Tax % | 35.6% | 35.6% | 31.0% | 27.1% | 25.1% | 27.1% | 19.2% | 28.1% | 26.6% | Sign in free for the trailing twelve months |
| Net profit | 433 Cr | 375 Cr | 419 Cr | 433 Cr | 652 Cr | 576 Cr | 678 Cr | 675 Cr | 857 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹133.31 | ₹115.40 | ₹129.12 | ₹133.42 | ₹200.79 | ₹177.37 | ₹208.91 | ₹207.95 | ₹263.86 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 169.3% | 98.7% | 69.4% | 127.4% | 98.5% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 32 Cr | 32 Cr | 32 Cr | 32 Cr | 32 Cr | 32 Cr | 32 Cr | 32 Cr | 32 Cr |
| Reserves | 494 Cr | 773 Cr | 877 Cr | 1,125 Cr | 682 Cr | 705 Cr | 914 Cr | 742 Cr | 721 Cr |
| Borrowings | — | — | — | — | — | — | — | — | — |
| Other liabilities | 634 Cr | 620 Cr | 723 Cr | 671 Cr | 918 Cr | 944 Cr | 1,191 Cr | 1,084 Cr | 1,050 Cr |
| Total liabilities | 1,160 Cr | 1,425 Cr | 1,632 Cr | 1,828 Cr | 1,633 Cr | 1,681 Cr | 2,137 Cr | 1,859 Cr | 1,804 Cr |
| Fixed assets (net) | 286 Cr | 250 Cr | 234 Cr | 207 Cr | 184 Cr | 164 Cr | 170 Cr | 139 Cr | 163 Cr |
| CWIP | 41 Cr | 21 Cr | 15 Cr | 22 Cr | 38 Cr | 44 Cr | 23 Cr | 28 Cr | 21 Cr |
| Investments | — | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Loans & advances | — | 99 Cr | 101 Cr | 6 Cr | 6 Cr | 6 Cr | 4 Cr | 4 Cr | 5 Cr |
| Inventories | 177 Cr | 124 Cr | 203 Cr | 205 Cr | 249 Cr | 234 Cr | 220 Cr | 226 Cr | 218 Cr |
| Trade receivables | 133 Cr | 148 Cr | 181 Cr | 166 Cr | 142 Cr | 191 Cr | 216 Cr | 241 Cr | 243 Cr |
| Cash & bank | 102 Cr | 392 Cr | 526 Cr | 884 Cr | 648 Cr | 625 Cr | 964 Cr | 574 Cr | 557 Cr |
| Other assets | 421 Cr | 390 Cr | 372 Cr | 338 Cr | 366 Cr | 418 Cr | 541 Cr | 648 Cr | 596 Cr |
| Total assets | 1,160 Cr | 1,425 Cr | 1,632 Cr | 1,828 Cr | 1,633 Cr | 1,681 Cr | 2,137 Cr | 1,859 Cr | 1,804 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 445 Cr | 415 Cr | 412 Cr | 474 Cr | 863 Cr | 573 Cr | 826 Cr | 471 Cr | 924 Cr |
| Cash from investing | 149 Cr | -19 Cr | 35 Cr | 75 Cr | 7 Cr | -27 Cr | -10 Cr | 1 Cr | 11 Cr |
| Cash from financing | -1,559 Cr | -106 Cr | -314 Cr | -191 Cr | -1,106 Cr | -569 Cr | -477 Cr | -862 Cr | -845 Cr |
| Net cash flow | -964 Cr | 290 Cr | 134 Cr | 358 Cr | -236 Cr | -23 Cr | 339 Cr | -390 Cr | 91 Cr |
| Free cash flow (OCF − Capex) | 401 Cr | 381 Cr | 396 Cr | 423 Cr | 832 Cr | 523 Cr | 781 Cr | 426 Cr | 924 Cr |
Ratios
| Metric | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 129.7% | 72.9% | 67.4% | 51.8% | 122.6% | 108.6% | 89.9% | 124.7% | 156.1% |
| ROE % | 82.2% | 46.5% | 46.1% | 37.4% | 91.3% | 78.1% | 71.7% | 87.1% | 113.7% |
| Debtor days | 20 | 22 | 22 | 20 | 14 | 18 | 20 | 21 | 21 |
| Inventory days | 105 | 83 | 78 | 70 | 80 | 68 | 94 | 107 | 107 |
| Days payable | 216 | 271 | 210 | 182 | 243 | 225 | 417 | 403 | 417 |
| Cash conversion cycle | -90 | -167 | -109 | -91 | -148 | -139 | -303 | -275 | -288 |
| OCF / EBITDA % | 67.0% | 67.5% | 67.6% | 78.5% | 97.6% | 69.1% | 95.1% | 48.5% | 78.9% |
| OCF / EBITDA % (3 years) | — | — | 67.4% | 71.2% | 83.4% | 82.4% | 87.6% | 70.0% | — |
| Debt / equity | — | — | — | 0.00 | — | — | — | — | — |
| Current ratio | 0.96 | 1.51 | 1.63 | 2.22 | 1.34 | 1.32 | 1.38 | 1.22 | 1.22 |
| Net debt / EBITDA | -0.15 | -0.64 | -0.86 | -1.46 | -0.73 | -0.75 | -1.11 | -0.59 | -0.48 |